← FDA DRUG APPROVALS

FDA ANDA · ANDA075591

FAMOTIDINE

Sponsor: BAXTER HLTHCARE

APPLICATION
ANDA075591
TYPE
ANDA
ORIGINAL APPROVAL
2001-05-10
LATEST ACTION
2024-08-20
ROUTE
INTRAVENOUS, INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription

Products

FAMOTIDINE PRESERVATIVE FREE IN PLASTIC CONTAINERPrescription
FAMOTIDINE 0.4MG/ML · INJECTABLE · INJECTION

Approval history

2024-08-20Labeling · Supplement 12 · standardAP
2015-04-06Labeling · Supplement 7 · standardAP
2011-01-06Labeling · Supplement 3AP
2001-05-10OriginalLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →